Denmark’s study on Wegovy’s employment effects puts Novo Nordisk’s obesity franchise under a policy spotlight with potential for expanded government backing.
Novo Nordisk’s blockbuster drug exports drive Denmark’s GDP growth above eurozone levels, per Danske Bank, fueling a trade surplus and potentially strengthening…
Novo Nordisk’s market dominance ties Denmark’s economic fate to its stock performance, with recent downturns casting a shadow over the nation’s growth…
BioMar's IPO, Denmark's biggest since 2018, saw shares rally on debut as investors bet on sustainable aquaculture growth.
Denmark's GDP outlook upgrade driven by pharmaceutical exports underscores the economic influence of Novo Nordisk's Ozempic and Wegovy, lifting growth expectations and…
A Danish billionaire divested ISS shares sourced from Lego family holdings.
BioMar, a leading global fish feed supplier, is set to launch the largest initial public offering on the Copenhagen stock exchange since…
Maersk CEO sees passing higher oil shock costs to customers as crude prices surge, signaling rising shipping surcharges, inflationary pressure, and resilience…